FSD Pharma Inc. Subordinate Voting Shares
FSD Pharma Inc. is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative and inflammatory disorders. The three licensed drug candidates are LUCID-MS, a new chemical entity targeting Multiple Sclerosis, LUCID-PSYCH, a psychoactive molecule targeting Major Depressive Disorder, and FSD-PEA, an ultra-micronized Palmitoyl ethylamine with a favorable safety profile targeting inflammation.
FSD Pharma Inc. Subordinate Voting Shares (HUGE)
le 11 octobre/October 2019
FSD Pharma Inc. has announced a consolidation of its Class B Subordinate Voting shares on the basis of one (1) post-consolidation common share for every two hundred one (201) pre-consolidation common shares.
As a result, the outstanding shares of the company will be reduced to approximately 7,874,809.
The shares will begin trading on a consolidated basis and with a new CUSIP number on October 16, 2019.
The name and symbol will not change.